| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |